Clinical trial Recruiting at 1 site Observational Ages 18 and up

Mitral valve annulus sizing with cardiac CT and 3D transesophageal echocardiography

Official title: Mitral Valve Annulus Assessment, a Comparison Between 3D-TOE, CCT and Surgical Ring

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06797687 · Data updated 2026-11-12

This project will test whether preoperative cardiac CT and intraoperative 3D transesophageal echocardiography can provide mitral annulus measurements that match the surgeon's ring sizing for adults with severe mitral regurgitation undergoing repair.

More Mitral Regurgitation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Roma)
StatusRecruiting
StartedMarch 15, 2025
Main results expectedMarch 15, 2026
Study endsMay 15, 2026
Registry record updatedAugust 15, 2025
Trial IDNCT06797687 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with severe mitral regurgitation scheduled for surgical repair with planned annuloplasty ring implantation who have preoperative coronary CT and adequate intraoperative 3D transesophageal echocardiography reconstructions and provide informed consent.

Probably not a fit

Patients who undergo valve replacement instead of repair, those without the required CT or intraoperative 3D-TOE imaging, or those with insufficient image quality are unlikely to benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Surgeons traditionally select annuloplasty ring size intraoperatively using physical gauges placed on the anterior mitral leaflet under cardioplegia, which ignores annular shape and motion during the cardiac cycle. This observational protocol will compare quantitative mitral annulus measurements obtained from preoperative cardiac CT and intraoperative 3D transesophageal echocardiography with the prosthetic ring sizes implanted at surgery in adults with severe mitral regurgitation. Eligible patients must have high-quality preoperative coronary CT suitable for annulus measurement and adequate intraoperative 3D-TOE reconstructions. The analysis will characterize modality differences across the cardiac cycle and explore whether imaging-derived metrics correspond to the surgeon's chosen ring size.

Why it matters

Potential benefit: If successful, imaging-guided sizing could improve preoperative planning and lead to better-matched annuloplasty rings, potentially improving repair durability and operative efficiency.

How similar studies have gone: Three-dimensional transesophageal echocardiography is established for anatomo-functional mitral characterization, but direct comparisons of CT and 3D-TOE measurements versus surgeon-selected ring sizes remain limited and are still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older
* Patients with severe mitral valve regurgitation, with an indication for surgical treatment of the valvopathy and who have undergone cardiac surgery for mitral valve surgery with prosthetic ring implantation
* Pre-operative coronary CT scan as a diagnostic tool for the exclusion of coronary artery disease (in accordance with the guidelines for chronic coronary syndrome and valvulopathy) with adequate image quality to allow measurement of the mitral annulus
* Availability of adequate three-dimensional echocardiographic reconstructions of the mitral valve apparatus at the intraoperative transesophageal echocardiogram to allow measurements of the annulus
* Provision of informed consent prior to enrolment

Exclusion Criteria:

* Implantation of mitral valve prosthesis due to inability to perform mitral valve repair
* Unavailability of CCT scan
* Unavailability of intraoperative transesophageal echocardiogram
* Unavailability of informed consent

Where it's running

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Cardiologia
    Roma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Posterior Mitral Leaflet Replacement to Reduce Mitral Regurgitation

    This early feasibility trial tests the MR-ace Implant and Delivery System to see if it can reduce symptoms and leaks in people with moderate-to-severe functional mitral regurgitation.

    Recruiting Polares Medical SA · Atlanta, Georgia and 2 other locations · NCT07517588

  • Replacing the native mitral valve with the ReValve System

    This study will test whether replacing the native mitral valve with the ReValve System helps adults with symptomatic, clinically significant mitral regurgitation who are appropriate candidates for mitral valve surgery.

    Recruiting at 3 sites Phase 1 ReValve Solutions Inc. · Tbilisi and 2 other locations · NCT07450911

  • Mitral valve replacement with the SATURN TMVR system for severe mitral regurgitation

    This study tests whether the SATURN TS transcatheter mitral valve replacement can be safely implanted and work well in adults with severe mitral regurgitation who are high-risk for open-heart surgery.

    Recruiting at 2 sites InnovHeart · Los Angeles, California and 4 other locations · NCT07130994

  • Outcomes after new edge-to-edge mitral valve repair

    This project will follow people with mitral regurgitation who receive transcatheter edge-to-edge repair at Amsterdam UMC to see how they do long-term and whether patient selection can be improved.

    Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT07108907

  • Surgical implantation of a polymer prosthetic mitral or aortic valve

    This will test a surgically implanted polymer heart valve to see if it is safe and works well for adults who need mitral or aortic valve replacement.

    Recruiting Mitrassist Lifesciences Limited Co., Ltd. · Shanghai, Shanghai Municipality · NCT07097740

  • GeminiOne transcatheter edge-to-edge repair for severe symptomatic mitral regurgitation

    This trial will try the GeminiOne TEER system to treat adults with severe, symptomatic mitral regurgitation who are high surgical risk or have not improved with medical therapy.

    Recruiting Sierra Valve LLC · Thousand Oaks, California · NCT07086534

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.